Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What's happened to catabolin?

H Sheppeard1, K G Couchman

  • 1Rheumatology Research Laboratory, Palmerston North Hospital, New Zealand.

Rheumatology International
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.

Human molecular genetics·2000
Same author

Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.

Anaesthesia and intensive care·1992
Same author

Rheumatic disease in a Philippine village. II: a WHO-ILAR-APLAR COPCORD study, phases II and III.

Rheumatology international·1991
Same author

Rehabilitation in chronic back pain: employment status after four years.

The New Zealand medical journal·1990
Same author

Cauda equina syndrome in ankylosing spondylitis diagnosed by computed tomography.

The New Zealand medical journal·1987
Same author

Transcutaneous electrical nerve stimulation (TNS) and its relationship to placebo therapy: a review.

The New Zealand medical journal·1987
Same journal

Predominant HLA class I associations with lupus nephritis susceptibility, histology class and reduced renal function in patients with systemic lupus erythematosus: a retrospective case-control study.

Rheumatology international·2026
Same journal

Post-stroke rehabilitation in inflammatory rheumatic diseases: outcome measures, digital tools, and patient education perspectives.

Rheumatology international·2026
Same journal

A diagnostic pitfall in suspected giant cell arteritis: metastatic renal cell carcinoma mimicking the temporal artery halo sign on ultrasound.

Rheumatology international·2026
Same journal

Health education needs of the Brazilian population with rheumatoid arthritis: mixed-methods cross-sectional study.

Rheumatology international·2026
Same journal

Barriers to and facilitators of maintaining physical activity for people with hip and knee osteoarthritis: a mixed-methods systematic review.

Rheumatology international·2026
Same journal

Investigation of factors affecting exercise perception in women with rheumatoid arthritis: a cross-sectional study.

Rheumatology international·2026
See all related articles

Research shows catabolin is interleukin-1, offering insights into arthritis. This discovery aids understanding cellular interactions and matrix metabolism in joints, paving the way for new arthritis treatments.

Area of Science:

  • Rheumatology and Immunology
  • Cellular Biology
  • Biochemistry

Background:

  • Arthritis research often faces increasing complexity.
  • Independent studies show convergence regarding catabolin's role.

Purpose of the Study:

  • To summarize the convergence of research on catabolin and its identification with interleukin-1.
  • To highlight the impact of catabolin/interleukin-1 research on understanding arthritic joints and matrix metabolism.

Main Methods:

  • Literature review and synthesis of independent research findings.
  • Analysis of cellular interactions and matrix metabolism in arthritic joints.

Main Results:

  • Catabolin is identified as interleukin-1 (IL-1).

Related Experiment Videos

  • Catabolin/IL-1 research has significantly advanced understanding of cellular interactions within the arthritic joint.
  • This research provides a tool to study matrix metabolism.

    • Conclusions:

    • The identification of catabolin with IL-1 simplifies arthritis research.
    • Future research directions include characterizing natural inhibitors and developing IL-1-modulating therapies for arthritis.
    • Further investigation into catabolin's specific functions, like chondrocyte stimulation and matrix degradation, is warranted.